187 related articles for article (PubMed ID: 37017636)
21. Heterozygous APC germline mutations impart predisposition to colorectal cancer.
Preisler L; Habib A; Shapira G; Kuznitsov-Yanovsky L; Mayshar Y; Carmel-Gross I; Malcov M; Azem F; Shomron N; Kariv R; Hershkovitz D; Ben-Yosef D
Sci Rep; 2021 Mar; 11(1):5113. PubMed ID: 33664379
[TBL] [Abstract][Full Text] [Related]
22. The concerted action of oncogenic driver mutations directs global translation in intestinal epithelial cells.
Smit W; Heijmans J
Mol Cell Oncol; 2021; 8(4):1879614. PubMed ID: 34616863
[TBL] [Abstract][Full Text] [Related]
23. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation.
Le Rolle AF; Chiu TK; Zeng Z; Shia J; Weiser MR; Paty PB; Chiu VK
Oncotarget; 2016 Jan; 7(3):2159-74. PubMed ID: 26744320
[TBL] [Abstract][Full Text] [Related]
25. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
26. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
[TBL] [Abstract][Full Text] [Related]
27. Computational quantification of global effects induced by mutations and drugs in signaling networks of colorectal cancer cells.
Sommariva S; Caviglia G; Ravera S; Frassoni F; Benvenuto F; Tortolina L; Castagnino N; Parodi S; Piana M
Sci Rep; 2021 Oct; 11(1):19602. PubMed ID: 34599254
[TBL] [Abstract][Full Text] [Related]
28. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer: a multipathway disease.
Jass JR
Crit Rev Oncog; 2006 Dec; 12(3-4):273-87. PubMed ID: 17425506
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
[TBL] [Abstract][Full Text] [Related]
31. Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance.
Morkel M; Riemer P; Bläker H; Sers C
Oncotarget; 2015 Aug; 6(25):20785-800. PubMed ID: 26299805
[TBL] [Abstract][Full Text] [Related]
32. Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations.
Fischer M; Yen WC; Kapoun AM; Wang M; O'Young G; Lewicki J; Gurney A; Hoey T
Cancer Res; 2011 Mar; 71(5):1520-5. PubMed ID: 21193546
[TBL] [Abstract][Full Text] [Related]
33. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis.
Bennecke M; Kriegl L; Bajbouj M; Retzlaff K; Robine S; Jung A; Arkan MC; Kirchner T; Greten FR
Cancer Cell; 2010 Aug; 18(2):135-46. PubMed ID: 20708155
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.
Riemer P; Rydenfelt M; Marks M; van Eunen K; Thedieck K; Herrmann BG; Blüthgen N; Sers C; Morkel M
J Cell Biol; 2017 Jun; 216(6):1567-1577. PubMed ID: 28442534
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.
Corso G; Pascale V; Flauti G; Ferrara F; Marrelli D; Roviello F
Eur J Hum Genet; 2013 Dec; 21(12):1383-8. PubMed ID: 23572025
[TBL] [Abstract][Full Text] [Related]
36. Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients.
Jiang L; Huang J; Morehouse C; Zhu W; Korolevich S; Sui D; Ge X; Lehmann K; Liu Z; Kiefer C; Czapiga M; Su X; Brohawn P; Gu Y; Higgs BW; Yao Y
Cancer Genet; 2013; 206(9-10):330-9. PubMed ID: 24200637
[TBL] [Abstract][Full Text] [Related]
37. Regulation of intestinal myofibroblasts by KRas-mutated colorectal cancer cells through heparin-binding epidermal growth factor-like growth factor.
Kawasaki H; Saotome T; Usui T; Ohama T; Sato K
Oncol Rep; 2017 May; 37(5):3128-3136. PubMed ID: 28339087
[TBL] [Abstract][Full Text] [Related]
38. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic KRAS suppresses store-operated Ca
Pierro C; Zhang X; Kankeu C; Trebak M; Bootman MD; Roderick HL
Cell Calcium; 2018 Jun; 72():70-80. PubMed ID: 29748135
[TBL] [Abstract][Full Text] [Related]
40. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer.
Zhu G; Pei L; Xia H; Tang Q; Bi F
Mol Cancer; 2021 Nov; 20(1):143. PubMed ID: 34742312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
